A study of pattern of use for gadolinium-based contrast agents (GBCAs) in patients undergoing contrast-enhanced magnetic resonance (CE-MR) examination - a prospective, multicentre, observational study (GBCA Observational study)

21/11/2017
14/03/2024
EU PAS number:
EUPAS21473
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Spontaneous reports of suspected adverse drug reactions
Other

Data sources (types), other

Prospective patient-based data collection
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures

Procedure of results generation

English (1.02 MB - PDF) View document